Mallinckrodt
Mallinckrodt illegally inflated price of drug from $50 to $32,000, DoJ lawsuit says
June 7, 2019Business Services Achthar, DoJ, Mallinckrodt, Medicare, co-pay, pharma
The Department of Justice (DoJ) has filed new charges against Mallinckrodt alleging the Irish-listed firm illegally hiked the price of …
FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone
December 12, 2018Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma
Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …
Mallinckrodt gets two thumbs down from FDA for jaundice drug
May 4, 2018Medical Communications, Sales and Marketing InfaCare, Mallinckrodt, biotech, drugs, pharma, pharmaceutical
Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the …
Mallinckrodt bolsters business with $1.2bn buyout
January 3, 2018Research and Development, Sales and Marketing Mallinckrodt, drugs, pharma, pharmaceutical, sucampo
Mallinckrodt has endured a tough 2017, with its share price falling by half over the course of the year. This …
Company in 85,000% infant epilepsy drug price increase receives $100 million fine
January 23, 2017Sales and Marketing Mallinckrodt, Martin Skhreli
Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …
